{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04998396",
            "orgStudyIdInfo": {
                "id": "CVN-102"
            },
            "organization": {
                "fullName": "Aspa Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of AAV9 Gene Therapy in Participants With Canavan Disease",
            "officialTitle": "A Phase 1/2 Open-Label Study of the Safety and Clinical Activity of Gene Therapy for Canavan Disease Through Administration of an Adeno-Associated Virus (AAV) Serotype 9-Based Recombinant Vector Encoding the Human ASPA Gene",
            "acronym": "CANaspire",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-gene-therapy-in-participants-with-canavan-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2021-09-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-10-13",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-10-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-08-05",
            "studyFirstSubmitQcDate": "2021-08-09",
            "studyFirstPostDateStruct": {
                "date": "2021-08-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-06",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-07",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Aspa Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The main objective of this trial is to evaluate the safety, tolerability, and pharmacodynamic activity of BBP-812, an investigational AAV9-based gene therapy, in pediatric participants with Canavan disease.",
            "detailedDescription": "Canavan disease is an ultra-rare, profoundly disabling and fatal disease with no approved therapy. The Sponsor is developing BBP-812, an investigational gene therapy product for systemic delivery in participants with Canavan disease. BBP-812 is a recombinant adeno-associated virus serotype 9 (rAAV9) vector engineered to deliver the aspartoacylase (ASPA) transgene under control of a ubiquitous promoter to restore ASPA expression in both neuronal and non-neuronal cell types."
        },
        "conditionsModule": {
            "conditions": [
                "Canavan Disease"
            ],
            "keywords": [
                "Canavan Disease",
                "AAV",
                "AAV9",
                "Gene therapy",
                "Aspartoacylase",
                "ASPA",
                "ASPA gene",
                "rAAV9",
                "ACY2",
                "Aminoacylase 2",
                "Spongy degeneration",
                "N-acetyl-L-aspartic acid (NAA)",
                "N-acetylaspartate",
                "Rare disease",
                "Inherited Metabolic Disorders",
                "Leukodystrophy",
                "Leukoencephalopathies",
                "Autosomal Recessive Disorder",
                "Neurodevelopmental diseases"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 26,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose-Finding Phase: BBP-812 Dose Level 1 (Cohort 1)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive a single intravenous (IV) infusion of low-dose BBP-812 on Day 0 in the dose-finding phase of the study.",
                    "interventionNames": [
                        "Biological: AAV9 BBP-812"
                    ]
                },
                {
                    "label": "Dose-Finding Phase: BBP-812 Dose Level 2 (Cohort 2)",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive a single IV infusion of high-dose BBP-812 on Day 0 in the dose-finding phase of the study.",
                    "interventionNames": [
                        "Biological: AAV9 BBP-812"
                    ]
                },
                {
                    "label": "Enrollment Expansion Phase: BBP-812",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive a single IV infusion of BBP-812 at the selected dose from the dose-finding phase on Day 0 in expansion phase of the study.",
                    "interventionNames": [
                        "Biological: AAV9 BBP-812"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "AAV9 BBP-812",
                    "description": "Sterile solution for injection for 1-time use via volumetric infusion pump",
                    "armGroupLabels": [
                        "Dose-Finding Phase: BBP-812 Dose Level 1 (Cohort 1)",
                        "Dose-Finding Phase: BBP-812 Dose Level 2 (Cohort 2)",
                        "Enrollment Expansion Phase: BBP-812"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants with Adverse Events (AEs)",
                    "timeFrame": "Baseline up to Week 52"
                },
                {
                    "measure": "Change from Baseline to 12 Months Post-Infusion in Urine N-acetylaspartate (NAA) Levels",
                    "timeFrame": "Baseline, Month 12"
                },
                {
                    "measure": "Change from Baseline to 12 Months Post-Infusion in Central Nervous System (CNS) NAA, as Measured by Magnetic Resonance Spectroscopy (MRS)",
                    "timeFrame": "Baseline, Month 12"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from Baseline to Week 52 in Gross Motor Assessment, Gross Motor Function Measure-88",
                    "timeFrame": "Baseline, Week 52"
                },
                {
                    "measure": "Change from Baseline to Week 52 in Fine Motor Assessment, Bayley-4",
                    "timeFrame": "Baseline, Week 52"
                },
                {
                    "measure": "Change from Baseline to Week 52 in Cognitive Assessment, Bayley-4",
                    "timeFrame": "Baseline, Week 52"
                },
                {
                    "measure": "Change from Baseline to Week 52 in Communication Assessment, Bayley-4",
                    "timeFrame": "Baseline, Week 52"
                },
                {
                    "measure": "Change from Baseline to Week 52 in Adaptive Function, Vineland-3",
                    "timeFrame": "Baseline, Week 52"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Maximum age for inclusion is 30 months.\n* Participant has stable health in the opinion of the investigator and as confirmed by medical history and laboratory studies with no acute or chronic hematologic, renal, liver, immunologic, or neurologic disease (other than Canavan disease).\n* Participant has biochemical, genetic, and clinical diagnosis of Canavan disease:\n\n  * Elevated urinary NAA and\n  * Biallelic mutation of the ASPA gene determined at Screening or documented in the participant's medical history.\n  * Active clinical signs of Canavan disease\n\nKey Exclusion Criteria:\n\n* Tests positive for total anti-AAV9 antibodies determined by enzyme-linked immunosorbent assay (ELISA).\n* Received prior gene therapy or other therapy (including vaccines) involving AAV.\n* Participant is receiving high-dose therapy with immunosuppressants.\n* Participant has significantly progressed Canavan disease characterized as:\n\n  * Presence of continuous/constant decerebrate or decorticate posturing,\n  * Recurrent status epilepticus, or\n  * Recalcitrant seizures that do not respond while on 3 or more anti-epileptic medications",
            "healthyVolunteers": false,
            "sex": "ALL",
            "maximumAge": "30 Months",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Michelle Nelken",
                    "role": "CONTACT",
                    "phone": "833-764-2267 or 617-861-4617",
                    "email": "CANaspire@aspatx.com"
                },
                {
                    "name": "clinicaltrials@aspatx.com",
                    "role": "CONTACT"
                }
            ],
            "locations": [
                {
                    "facility": "UCSF Benioff Children's Hospital Oakland",
                    "status": "RECRUITING",
                    "city": "Oakland",
                    "state": "California",
                    "zip": "94609",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Marissa Evans",
                            "role": "CONTACT",
                            "phone": "510-428-3885",
                            "phoneExt": "5421",
                            "email": "Marissa.Evans@ucsf.edu"
                        },
                        {
                            "name": "Annie Salko",
                            "role": "CONTACT",
                            "phone": "510-428-3885",
                            "phoneExt": "7217",
                            "email": "Annie.Sako@ucsf.edu"
                        },
                        {
                            "name": "Alexander Fay, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.80437,
                        "lon": -122.2708
                    }
                },
                {
                    "facility": "Ann & Robert H. Lurie Children's Hospital of Chicago",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alexandra (Ally) Byrd",
                            "role": "CONTACT",
                            "phone": "312-227-0067",
                            "email": "albyrd@luriechildrens.org"
                        },
                        {
                            "name": "Jennifer Rubin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "Massachusetts General Hospital (MGH); Center for Rare Neurological Diseases (CRND)",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Riya Saxena",
                            "role": "CONTACT",
                            "phone": "603-674-6743",
                            "email": "rsaxena2@mgh.harvard.edu"
                        },
                        {
                            "name": "Damilola Oje",
                            "role": "CONTACT",
                            "phone": "401-248-8558",
                            "email": "doje@mgh.harvard.edu"
                        },
                        {
                            "name": "Florian Eichler, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Weill Cornell Medicine; Division of Pediatric Neurology",
                    "status": "COMPLETED",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Aspa Therapeutics Company Website",
                    "url": "http://aspatx.com"
                },
                {
                    "label": "Canavan Disease Program Website",
                    "url": "http://treatcanavan.com"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017825",
                    "term": "Canavan Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020279",
                    "term": "Hereditary Central Nervous System Demyelinating Diseases"
                },
                {
                    "id": "D000020739",
                    "term": "Brain Diseases, Metabolic, Inborn"
                },
                {
                    "id": "D000001928",
                    "term": "Brain Diseases, Metabolic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000056784",
                    "term": "Leukoencephalopathies"
                },
                {
                    "id": "D000003711",
                    "term": "Demyelinating Diseases"
                },
                {
                    "id": "D000020271",
                    "term": "Heredodegenerative Disorders, Nervous System"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M24518",
                    "name": "Rare Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28591",
                    "name": "Leukoencephalopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M20017",
                    "name": "Canavan Disease",
                    "asFound": "Canavan Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6909",
                    "name": "Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22099",
                    "name": "Hereditary Central Nervous System Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5205",
                    "name": "Brain Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22498",
                    "name": "Brain Diseases, Metabolic, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22092",
                    "name": "Heredodegenerative Disorders, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "T3395",
                    "name": "Leukodystrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "T930",
                    "name": "Canavan Disease",
                    "asFound": "Canavan Disease",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M18659",
                    "name": "N-Methylaspartate",
                    "relevance": "LOW"
                },
                {
                    "id": "T3",
                    "name": "Aspartic Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}